Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Radiotherapy

 

Booster blunder puts staff at risk

The Indian government's slowness to approve booster shots is putting lives at risk - particularly those of front line medical staff whose immunity is waning. HBI speaks to a disappointed operator source in the country to find out more.

Double radiotherapy deals in Romania and Germany

Romania's largest healthcare provider Medlife says it has Balkan ambitions while acquiring half of regional oncology provider Neolife. The emergence of pan-EU players continues after the infrastructure investor that earlier bought Medipass, has bought a 14+ clinic network in Germany. 

Treatment, not terrorism: Medical machines threaten global security

Ageing cobalt-based radiation therapy machines pose a threat to global national security, and moves are afoot by the World Institute for Nuclear Security to see them decommissioned, replaced, and their active elements safely disposed of before they fall into terrorist hands.

Proton therapy accelerates

Investors and states have ploughed capex into new proton therapy machines across Europe as the machines get smaller, the range of use cases grows and more private insurers start to cover the therapy.

HCG sells Strand minority stake to Reliance

Indian oncology hospital group HealhCare Global Enterprises (HCG) has sold its minority stake in life sciences company Strand after buying in full its oncology lab and clinical trials business.

Huge PPPs pile up for waiting lists

HBI unpicks where the private sector is winning contracts to help manage sky-high backlogs. Nearly £30bn is up for grabs in elective care, oncology and diagnostics. 

MedEuropa acquisition heralds start of PE radiotherapy consolidation spree

The fragmented German radiotherapy market is starting to pique the interest of private equity, as many doctors reach retirement age. Pan-EU platform MedEuropa has acquired a three-centre group in the northwest, and CEO Ralph Hefti tells HBI that its model of co-investing alongside doctors is likely to win out consolidation efforts.

Find Us